n
a
v
Portfolio
Genetics
AmplideX® Fragile X Dx & Carrier Screen Kit
AmplideX® mPCR FMR1 Kit
AmplideX® PCR/CE FMR1 Kit
AmplideX® FMR1 Controls
Xpansion Interpreter®
AmplideX® PCR/CE
SMN1/2
Plus Kit
AmplideX® PCR/CE
CFTR
Kit
AmplideX® PCR/CE C9orf72 Kit
AmplideX® PCR/CE
DMPK
Kit
AmplideX® PCR/CE
HTT
Kit
AmplideX® TRIO
Oncology
QuantideX® qPCR BCR-ABL IS Kit
QuantideX® qPCR BCR-ABL minor Kit
MolecularDx Controls
Catalog of Armored Products
SARS CoV-2 Controls
Made-To-Order Armored and Nucleic Acid
Molecular Assay Reagents
Custom & Companion Diagnostics
Partnered R&D
CAP-Accredited CLIA Lab
CTA Testing Site
Validated Platforms & Assays
Companion Diagnostics
Enabling Technologies
Assay Chemistries
Bioinformatics
Product Development Process
Resources
Publications
Articles
Whitepapers
Posters
Disease Information
Fragile X Syndrome
Dementia
Other Resources
Videos
Carrier Screening Guide
Safety Data Sheets
Sales Contacts
Our Culture
Employee Spotlights
Culture & Heritage
Sales Contacts
About
Leadership Team
Culture and Heritage
News
Upcoming Events
Business Development
Contact
Careers
Search
News
Home
News
Press Releases
Year
Select Year
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
December 1, 2022
BIO-TECHNE AND OXFORD NANOPORE TECHNOLOGIES PARTNER TO BRING INNOVATIVE REPRODUCTIVE HEALTH AND CARRIER SCREENING SOLUTIONS TO THE MARKET
Share
October 31, 2022
ASURAGEN TO SHOWCASE INNOVATIVE DIAGNOSTIC LAB SOLUTIONS AT AMP 2022 CONFERENCE
Share
November 4, 2021
Asuragen Launches New Kit to Enable Broader Coverage of Gene Variants Linked to Cystic Fibrosis
Share
November 10, 2020
Asuragen to Present at Association for Molecular Pathology (AMP) 2020 Annual Meeting
Share
August 3, 2020
Pacific Biosciences and Asuragen Collaborate to Develop Assays for Carrier Screening and other Applications Based on SMRT Sequencing Technology and AmplideX PCR Chemistry
Share
July 7, 2020
Asuragen Announces CE Mark of AmplideX® SMA Plus Kit
Share
June 2, 2020
Asuragen to Present at 2020 European Society of Human Genetics (ESHG) Virtual Conference
Share
March 16, 2020
Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control
Share
February 24, 2020
FDA Grants Premarket Clearance of Asuragen’s AmplideX® Fragile X Dx and Carrier Screen Kit
Share
November 25, 2019
Asuragen Partners with Wave Life Sciences to Develop Companion Diagnostics for Huntington’s Disease
Share
1
2
3
4
5
6
7
8
Next
About
About
Leadership Team
Culture and Heritage
News
Upcoming Events
Business Development
Back To
Top
